{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:43:13Z","timestamp":1793720593621,"version":"4.6.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81172870"],"award-info":[{"award-number":["81172870"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis (DM)-associated interstitial lung disease (ILD) may progress rapidly and lead to high mortality within 6 or 12 months. Except for reported prognostic factors, simple but powerful prognostic biomarkers are still in need in practice. In this study, we focused on circulating monocyte and lymphocyte counts and their variation tendency in the early stage of ILD. A total of 351 patients from two inception anti-MDA5 antibody-positive cohorts were included in this study, with various treatment choices. Lymphocyte count remained lower in the first month after admission in the non-survivor patients. Although baseline monocyte count showed no significant differences, average monocyte count in the following 4 weeks was also lower in the non-survivor group. Based on the C-index and analysis by the \u201csurvminer\u201d R package in the discovery cohort, we chose 0.24 \u00d7 109\/L as the cutoff value for Mono W0-2, 0.61 \u00d7 109\/L as the cutoff value for lymph W0-2, and 0.78 \u00d7 109\/L as the cutoff value for peripheral blood mononuclear cell (PBMC) W0-2, to predict the 6-month all-cause mortality. The Kaplan\u2013Meier survival curves and adjusted hazard ratio with age, gender, and the number of immunosuppressants used all validated that patients with lower average monocyte count, lower average lymphocyte count, or lower average PBMC count in the first 2 weeks after admission had higher 6-month death risk, no matter in the validation cohort or in the pooled data. Furthermore, flow cytometry figured out that non-classical monocytes in patients with anti-MDA5 antibody-positive DM were significantly lower than healthy controls and patients with DM without anti-MDA5 antibodies. In conclusion, this study elucidated the predictive value of monocyte and lymphocyte counts in the early stage and may help rheumatologists to understand the possible pathogenesis of this challenging disease.<\/jats:p>","DOI":"10.3389\/fmed.2021.808875","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:05:52Z","timestamp":1642377952000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Low Circulating Monocytes Is in Parallel With Lymphopenia Which Predicts Poor Outcome in Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis-Associated Interstitial Lung Disease"],"prefix":"10.3389","volume":"8","author":[{"given":"Xia","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12016-020-08822-5","article-title":"Interstitial lung disease in Anti-MDA5 positive dermatomyositis","volume":"60","author":"Wu","year":"2021","journal-title":"Clin Rev Allergy Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/art.41566","article-title":"Risk prediction modeling based on a combination of initial serum biomarker levels in polymyositis\/dermatomyositis-associated interstitial lung disease","volume":"73","author":"Gono","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e22978","DOI":"10.1002\/jcla.22978","article-title":"Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease","volume":"33","author":"Ye","year":"2019","journal-title":"J Clin Lab Anal."},{"key":"B4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1136\/ard.59.4.257","article-title":"Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis\/dermatomyositis","volume":"59","author":"Bandoh","year":"2000","journal-title":"Ann Rheum Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/rheumatology\/keq149","article-title":"Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis","volume":"49","author":"Gono","year":"2010","journal-title":"Rheumatology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.chest.2020.04.057","article-title":"Mortality risk prediction in amyopathic dermatomyositis associated with interstitial lung disease: the FLAIR model","volume":"158","author":"Lian","year":"2020","journal-title":"Chest."},{"key":"B7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/rheumatology\/key341","article-title":"CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease","volume":"58","author":"Wang","year":"2019","journal-title":"Rheumatology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/rheumatology\/keab305","article-title":"Forced vital capacity predicts the survival of interstitial lung disease in anti-MDA5 positive dermatomyositis: a multi-centre cohort study","volume":"21","author":"Wu","year":"2021","journal-title":"Rheumatology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"17070","DOI":"10.1038\/s41598-021-96292-w","article-title":"A novel CT scoring method predicts the prognosis of interstitial lung disease associated with anti-MDA5 positive dermatomyositis","volume":"11","author":"Xu","year":"2021","journal-title":"Sci Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10067-015-3139-z","article-title":"Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis","volume":"35","author":"Xu","year":"2016","journal-title":"Clin Rheumatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2024869","DOI":"10.1155\/2020\/2024869","article-title":"Predictors of poor outcome of Anti-MDA5-associated rapidly progressive interstitial lung disease in a chinese cohort with dermatomyositis","volume":"2020","author":"Li","year":"2020","journal-title":"J Immunol Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.immuni.2018.10.005","article-title":"Developmental and functional heterogeneity of monocytes","volume":"49","author":"Guilliams","year":"2018","journal-title":"Immunity."},{"key":"B13","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nri3070","article-title":"Monocyte recruitment during infection and inflammation","volume":"11","author":"Shi","year":"2011","journal-title":"Nat Rev Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S2213-2600(18)30508-3","article-title":"Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study","volume":"7","author":"Scott","year":"2019","journal-title":"Lancet Respir Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12931-021-01725-9","article-title":"Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis","volume":"22","author":"Karampitsakos","year":"2021","journal-title":"Respir Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/00005792-200303000-00002","article-title":"Peripheral blood lymphocyte subset counts in patients with dermatomyositis: clinical correlations and changes following therapy","volume":"82","author":"Viguier","year":"2003","journal-title":"Medicine."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s10067-012-2075-4","article-title":"Clinical significance of peripheral blood lymphocyte subsets in patients with polymyositis and dermatomyositis","volume":"31","author":"Wang","year":"2012","journal-title":"Clin Rheumatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1093\/rheumatology\/keaa266","article-title":"The characteristics of lymphocytes in patients positive for anti-MDA5 antibodies in interstitial lung disease","volume":"59","author":"Huang","year":"2020","journal-title":"Rheumatology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3892\/mmr.2017.6693","article-title":"Potential role of autophagy in Tcell survival in polymyositis and dermatomyositis","volume":"16","author":"Shu","year":"2017","journal-title":"Mol Med Rep."},{"key":"B20","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARSCoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1002\/cbin.11403","article-title":"Lymphopenia in COVID-19: therapeutic opportunities","volume":"44","author":"Fathi","year":"2020","journal-title":"Cell Biol Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/rheumatology\/ket279","article-title":"Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy","volume":"53","author":"Venalis","year":"2014","journal-title":"Rheumatology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.4049\/jimmunol.175.3.1820","article-title":"Depletion of T cells by type I interferon: differences between young and aged mice","volume":"175","author":"Jiang","year":"2005","journal-title":"J Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1182\/blood-2006-06-027599","article-title":"Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia","volume":"108","author":"Kamphuis","year":"2006","journal-title":"Blood."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1378\/chest.08-2740","article-title":"Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis","volume":"136","author":"Mukae","year":"2009","journal-title":"Chest."},{"key":"B26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1164\/rccm.202003-0669OC","article-title":"Monocyte count as a prognostic biomarker in patients with idiopathic pulmonary fibrosis","volume":"204","author":"Kreuter","year":"2021","journal-title":"Am J Respir Crit Care Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1479973120909840","DOI":"10.1177\/1479973120909840","article-title":"Monocyte count and the risk for acute exacerbation of fibrosing interstitial lung disease: A retrospective cohort study","volume":"17","author":"Kawamura","year":"2020","journal-title":"Chron Respir Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat Immunol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00460-2019","article-title":"CX3CR1-fractalkine axis drives kinetic changes of monocytes in fibrotic interstitial lung diseases","volume":"55","author":"Greiffo","year":"2020","journal-title":"Eur Respir J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/cyto.a.24188","article-title":"Decrease of non-classical and intermediate monocyte subsets in severe acute SARS-CoV-2 infection","volume":"97","author":"Gatti","year":"2020","journal-title":"Cytometry A."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.cell.2020.08.002","article-title":"Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19","volume":"182","author":"Silvin","year":"2020","journal-title":"Cell."},{"key":"B32","doi-asserted-by":"publisher","first-page":"623430","DOI":"10.3389\/fimmu.2021.623430","article-title":"Multi-Modal characterization of monocytes in idiopathic pulmonary fibrosis reveals a primed type i interferon immune phenotype","volume":"12","author":"Fraser","year":"2021","journal-title":"Front Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/rheumatology\/keab371","article-title":"Antiviral proinflammatory phenotype of monocytes in anti-MDA5 antibody-associated interstitial lung disease","volume":"21","author":"Gono","year":"2021","journal-title":"Rheumatology (Oxford)."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.808875\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:05:54Z","timestamp":1642377954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.808875\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,17]]},"references-count":33,"alternative-id":["10.3389\/fmed.2021.808875"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.808875","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,17]]},"article-number":"808875"}}